CD-MEDICS

The overall concept of the CD-MEDICS IP is to develop a technology platform for point-of-care diagnostics, capable of simultaneous genomic and proteomic detection, with embedded communication abilities for direct interfacing with hospital information systems. This will be achieved by exploiting breakthroughs at the confluences of bio-, micro- and nano- technologies to create a low-cost non-invasive intelligent diagnosis system.

This platform will be developed in a modular format, which will allow each module to be developed and exploited individually. The modules will subsequently be integrated to facilitate the desired application. Advances in data communications, molecular biology and biosensor technology, with the integration of nanostructured functional components in macro and microsystems, will facilitate the realisation of a minimally invasive generic platform, which is capable of multi-parametric monitoring and will be interoperable with electronic medical records.

The advantages of integrated biosensor systems include their ease of use, their sensitivity, their inherent selectivity (preventing problems due to interfering substances), their versatility (allowing `in-field¿ use) and their cost effectiveness. Addressing the future health care requirement of an individualised theranostic approach, the specific application that will be demonstrated in this IP will be for the management, monitoring and diagnosis of coeliac disease, with the proposed technology contributing to significant advances in sensitivity and specificity of diagnosis. The technology platform developed, however, could be applied to a variety of clinical screening applications, such as cancer. The radical innovation proposed in this IP will result in a concrete prime deliverable of a technology platform of wide application and unquestionable socio-economic benefit, increasing European competitiveness whilst contributing considerably to the quality of life well being of the population.

For further information, please visit:
http://www.cdmedics.eu

Project co-ordinator:
Universitat Rovira i Virgili

Partners:

  • Institut für Mikrotechnik Mainz GmbH
  • Microfluidic ChipShop GmbH
  • Newcastle University
  • Intracom Telecom solutions
  • Clemens GmbH
  • Micro2Gen
  • Eurospital SpA
  • King's College London Business Ltd
  • INNO-TRAIN Diagnostik GmbH
  • TATAA Biocenter
  • MultiD Analyses AB
  • Finnish Red Cross Blood Service
  • Fondazione IRCCS Policlinico San Matteo
  • University Medical Centre Maribor
  • Valentia Technologies Limited
  • Association of European Coeliac Societies
  • Coeliac UK
  • Asociación de celíacos de Madrid
  • iXscient Ltd.
  • Newcastle upon Tyne Hospitals NHS Foundation Trust

Timetable: from 01/2008 – to 12/2011

Total cost: € 12.796.559

EC funding: € 9.500.000

Programme Acronym: FP7-ICT

Subprogramme Area: Personal health systems for monitoring and point-of-care diagnostics

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Doctors Rely on More than Just Data for …

Many technology companies are working on artificial intelligence systems that can analyze medical data to help diagnose or treat health problems. Such systems raise the question of whether this kind...

App, Brief Intervention may be Lifesaver…

A troubled teenager is hospitalized with suicidal thoughts. The patient is diagnosed, medicated, and counseled by a team of experts. The teen is sent home a few days later, and...

New Coalition of Philanthropists Includi…

Philanthropist Bill Gates and the Alzheimer's Drug Discovery Foundation (ADDF) co-founder Leonard Lauder have announced a new initiative, Diagnostics Accelerator, to develop novel biomarkers for the early detection of Alzheimer's...

IMI Launches New Antimicrobial Resistanc…

A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched today by the Innovative Medicines Initiative (IMI). Of the other topics launched in the Calls...

Wearable Devices and Mobile Health Techn…

With increasing efforts being made to address the current global obesity epidemic, wearable devices and mobile health ("mHealth") technology have emerged as promising tools for promoting physical activity. However, current...

Frontiers Health 2018

15 - 16 November 2018, Berlin, Germany. Frontiers Health has fast become one of the premiere conferences in the digital health space, combining a unique mix of attendees and presenters from...

Digital Health to Disrupt Health IT Mark…

25 - 26 March 2019, London, United Kingdom. Digital Health - publishers of digitalhealth.net and organisers of the CCIO, CNIO, CIO Networks and annual Summer Schools - is to shake up...

Bayer Cares Foundation Promotes Sustaina…

Grants4Impact (G4I), a new energizer program launched by Bayer Cares Foundation, is providing targeted support to social impact pioneers and start-ups in the fields of healthcare and nutrition. The aim...

Philips and Oxford University Hospitals …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Oxford University Hospitals (OUH) NHS Foundation Trust, announced plans to create a digital pathology network to help...

Maidstone and Tunbridge Wells NHS Trust …

Maidstone and Tunbridge Wells NHS Trust has selected Allscripts Sunrise as its electronic health record, in a move that further solidifies the company's position in the South East of England...

Start Alliance Berlin: Digital Health

Start Alliance Berlin: Digital Health is a two-week program taking place in November 2018 which is intended to help startups from BEIJING, DUBAI, NEW YORK, LONDON, PARIS, SHANGHAI, TEL AVIV...